CL logo

Cresco Labs Inc. Stock Price

CNSX:CL Community·CA$881.3m Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author

CL Share Price Performance

CA$1.85
-0.35 (-15.91%)
43.1% undervalued intrinsic discount
CA$3.25
Fair Value
CA$1.85
-0.35 (-15.91%)
43.1% undervalued intrinsic discount
CA$3.25
Fair Value
Price CA$1.85
AnalystHighTarget CA$3.25
AnalystConsensusTarget CA$2.15
AnalystLowTarget CA$1.51

CL Community Narratives

AnalystHighTarget·
Fair Value CA$3.25 40.3% undervalued intrinsic discount

Rising Cannabis Legalization And Wellness Trends Will Fuel Expansion

0users have liked this narrative
1users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value CA$2.16 10.1% undervalued intrinsic discount

Expanding Legal Markets Will Spur Cannabis Consolidation

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AnalystLowTarget·
Fair Value CA$1.51 28.1% overvalued intrinsic discount

Cannabis Markets Will Battle Price Compression While Gaining Cautious Relief

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent CL News & Updates

Is Cresco Labs Inc. (CSE:CL) Trading At A 49% Discount?

Sep 06
Is Cresco Labs Inc. (CSE:CL) Trading At A 49% Discount?

Optimistic Investors Push Cresco Labs Inc. (CSE:CL) Shares Up 27% But Growth Is Lacking

Jul 31
Optimistic Investors Push Cresco Labs Inc. (CSE:CL) Shares Up 27% But Growth Is Lacking

Cresco Labs (CSE:CL) Takes On Some Risk With Its Use Of Debt

Jul 23
Cresco Labs (CSE:CL) Takes On Some Risk With Its Use Of Debt

Cresco Labs Inc.'s (CSE:CL) 30% Share Price Plunge Could Signal Some Risk

Jun 15
Cresco Labs Inc.'s (CSE:CL) 30% Share Price Plunge Could Signal Some Risk

Cresco Labs Inc.'s (CSE:CL) Shares Climb 31% But Its Business Is Yet to Catch Up

May 01
Cresco Labs Inc.'s (CSE:CL) Shares Climb 31% But Its Business Is Yet to Catch Up

Cresco Labs Inc. Key Details

US$677.3m

Revenue

US$345.7m

Cost of Revenue

US$331.6m

Gross Profit

US$377.3m

Other Expenses

-US$45.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.13
Gross Margin
48.96%
Net Profit Margin
-6.74%
Debt/Equity Ratio
105.6%

Cresco Labs Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Undervalued with mediocre balance sheet.

2 Risks
3 Rewards

About CL

Founded
n/a
Employees
2900
CEO
Charles Bachtell
WebsiteView website
www.crescolabs.com

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy’s Edibles brand, as well as licenses the Kiva brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: -2.8%
  • 3 Months: 5.3%
  • 1 Year: 13.4%
  • Year to Date: 11.7%
Over the last 7 days, the market has dropped 2.8%, driven by a loss of 2.5% in the Information Technology sector. In contrast to the last week, the market is actually up 13% over the past year. Earnings are forecast to grow by 15% annually. Market details ›